المؤلفون: Desprez, B, Birk, B, Blaauboer, B, Boobis, A, Carmichael, P, Cronin, MTD, Curie, R, Daston, G, Hubesch, B, Jennings, P, Klaric, M, Kroese, D, Mahony, C, Ouédraogo, G, Piersma, A, Richarz, A-N, Schwarz, M, van Benthem, J, van de Water, B, Vinken, M

مصطلحات موضوعية: RM Therapeutics. Pharmacology

وصف الملف: text

Relation: https://researchonline.ljmu.ac.uk/id/eprint/10484/1/Paper%20Ontology%20for%20symplectic%203%20April%2019.pdf; Desprez, B, Birk, B, Blaauboer, B, Boobis, A, Carmichael, P, Cronin, MTD, Curie, R, Daston, G, Hubesch, B, Jennings, P, Klaric, M, Kroese, D, Mahony, C, Ouédraogo, G, Piersma, A, Richarz, A-N, Schwarz, M, van Benthem, J, van de Water, B and Vinken, M (2019) A mode-of-action ontology model for safety evaluation of chemicals: outcome of a series of workshops on repeated dose toxicity. Toxicology In Vitro. pp. 44-50. ISSN 0887-2333

الاتاحة: http://researchonline.ljmu.ac.uk/id/eprint/10484/
https://researchonline.ljmu.ac.uk/id/eprint/10484/1/Paper%20Ontology%20for%20symplectic%203%20April%2019.pdf
https://doi.org/10.1016/j.tiv.2019.04.005

المؤلفون: Desprez, B., Birk, B., Blaauboer, B., Boobis, A., Carmichael, P., Cronin, M.T.D., Curie, R., Daston, G., Hubesch, B., Jennings, P., Klaric, M., Kroese, D., Mahony, C., Ouédraogo, G., Piersma, A., Richarz, A.N., Schwarz, M., Benthem, J. van, Water, B. van de, Vinken, M.

المصدر: 59, 44-50

مصطلحات موضوعية: Adverse outcome pathway, Mode-of-action, Ontology model, Repeated dose toxicity, Cosmetic, Adverse outcome, Biotransformation, Chemical parameters, Chemical structure, Cytotoxicity, Exposure, Human, Kinetics, Metabolism, Mode of action, Nonhuman, Note, Ontology, Organ distribution, Physical chemistry, Safety, Toxicity testing, Toxicology, Workflow

Relation: uuid:fdd36fee-f5b2-4ab3-93cf-903c1fa866b4; 866701; http://resolver.tudelft.nl/uuid:fdd36fee-f5b2-4ab3-93cf-903c1fa866b4

الاتاحة: http://resolver.tudelft.nl/uuid:fdd36fee-f5b2-4ab3-93cf-903c1fa866b4

المؤلفون: Theoret, C. L., Barber, S. M., Curie, R. D., Clayton, Hilary M.

المصدر: Veterinary and Comparative Orthopaedics and Traumatology ; volume 11, issue 02, page 80-84 ; ISSN 0932-0814 2567-6911

الاتاحة: http://dx.doi.org/10.1055/s-0038-1632615
http://www.thieme-connect.de/products/ejournals/pdf/10.1055/s-0038-1632615.pdf

المؤلفون: Clayton, Hilary M., Theoret, C. L., Barber, S. M., Curie, R. D.

المصدر: VCOT (Veterinary & Comparative Orthopaedics and Traumatology); February 1998, Vol. 11 Issue: 2 p80-84, 5p

المؤلفون: Gentric, Géraldine, Kieffer, Yann, Mieulet, Virginie, Goundiam, Oumou, Bonneau, Claire, Némati, Fariba, Hurbain, Ilse, Raposo, Graça, Popova, Tatiana, Stern, Marc-Henri, Lallemand-Breitenbach, Valérie, Müller, Sebastian, Cañeque, Tatiana, Rodriguez, Raphaël, Vincent-Salomon, Anne, de Thé, Hugues, Rossignol, Rodrigue, Mechta-Grigoriou, Fatima

المساهمون: Unité de génétique et biologie des cancers (U830), Université Paris Descartes - Paris 5 (UPD5)-Institut Curie Paris -Institut National de la Santé et de la Recherche Médicale (INSERM), Département de Recherche Translationnelle, Institut Curie Paris, Compartimentation et dynamique cellulaires (CDC), Université Pierre et Marie Curie - Paris 6 (UPMC)-Institut Curie Paris -Centre National de la Recherche Scientifique (CNRS), BioImaging Cell and Tissue Core Facility (PICT-IBiSA), Pathologie et virologie moléculaire (PVM (UMR_7151)), Université Paris Diderot - Paris 7 (UPD7)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Chimie biologique des membranes et ciblage thérapeutique (CBMCT - UMR 3666 / U1143), Université Paris Descartes - Paris 5 (UPD5)-Institut Curie Paris -Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut de Chimie - CNRS Chimie (INC-CNRS)-Centre National de la Recherche Scientifique (CNRS), Département de Pathologie Curie, Collège de France - Chaire Oncologie cellulaire et moléculaire, Génomes, biologie cellulaire et thérapeutiques (GenCellDis (U944 / UMR7212)), Collège de France (CdF (institution))-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité)-Collège de France (CdF (institution))-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité), Laboratoire Maladies Rares: Génétique et Métabolisme (Bordeaux) (U1211 INSERM/MRGM), Université de Bordeaux (UB)-Groupe hospitalier Pellegrin-Institut National de la Santé et de la Recherche Médicale (INSERM), G.G. was supported by funding from the Foundation ARC. Y.K. was supported by the Foundation for Medical Research (FRM) and the SiRIC-Curie program (INCa-DGOS-4654). F.M.-G., C.B., and V.M. were supported by the Institut National de la Sante´ et de la Recherche Me´ dicale (Inserm). O.G. was funded by Institut Curie. R. Rodriguez is supported by ERC (grant number 647973). The experimental work was supported by grants from the Ligue Nationale Contre le Cancer (Labelisation), Institut Curie, Inserm (PC201317), INCa (2011-1-PLBIO-12-IC-1 and 2015-1-RT-04-ICR-1), and the Simone and Cino del Duca Foundation for the Grand Prix attributed to F.M.-G. F.M.-G is very grateful to her funders for providing support these last years., ANR-10-INBS-0004,France-BioImaging,Développment d'une infrastructure française distribuée coordonnée(2010), ANR-10-LABX-0038,P2IO,Physics of the 2 infinities and the origins(2010), ANR-11-INBS-0010,METABOHUB,Développement d'une infrastructure française distribuée pour la métabolomique dédiée à l'innovation(2011), ANR-11-LABX-0038,CelTisPhyBio,Des cellules aux tissus: au croisement de la Physique et de la Biologie(2011), European Project: 647973,H2020,ERC-2014-CoG,Drug-Seq(2015)

المصدر: ISSN: 1550-4131 ; Cell Metabolism ; https://inserm.hal.science/inserm-02437801 ; Cell Metabolism, 2019, 29 (1), pp.156-173.e10. ⟨10.1016/j.cmet.2018.09.002⟩.

مصطلحات موضوعية: OXPHOS, PGC-1α, chemoresistance, ferroptosis, ovarian cancer, oxidative stress, peroxisome proliferator-activated receptor gamma coactivator-1α, promyelocytic leukemia protein, reactive oxygen species, response to treatment, [SDV]Life Sciences [q-bio], [SDV.CAN]Life Sciences [q-bio]/Cancer

Relation: info:eu-repo/semantics/altIdentifier/pmid/30244973; info:eu-repo/grantAgreement//647973/EU/Unravelling the Genomic Targets of Drugs Using High-Throughput Sequencing/Drug-Seq; PUBMED: 30244973; PUBMEDCENTRAL: PMC6331342

الاتاحة: https://inserm.hal.science/inserm-02437801
https://inserm.hal.science/inserm-02437801v1/document
https://inserm.hal.science/inserm-02437801v1/file/2019_Gentric_Cell%20Metabolism_PML%20and%20OXPHOS%20in%20ovarian%20cancers_08Janv2019.pdf
https://doi.org/10.1016/j.cmet.2018.09.002

المساهمون: Edeline, Véronique [Department of Imaging, Institut Curie R. Huguenin Hospital, Saint-Cloud (France)]

المصدر: International Journal of Radiation Oncology, Biology and Physics; 89; 5; Other Information: Copyright (c) 2014 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.; Country of input: International Atomic Energy Agency (IAEA)

وصف الملف: Medium: X; Size: page(s) 1047-1052

URL الوصول: http://www.osti.gov/scitech/biblio/22420392